Patent Assignment
Reel/Frame 050352/0447
Change of Name
Recorded: 2019-09-12
Pages: 6
Assignor
NLS-1 PHARMA AG
Executed: 2019-07-17
Assignee
NLS PHARMACEUTICS AG
ALTER POSTPLATZ 2, STANS, 6370, SWITZERLAND
Covered Property
(1)
Phacetoperane for Treating of Attention Deficit Hyperactivity Disorder
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.